Table 1.
Quality assessment of included studies.
| No. | Authors | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | Score | References |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ress et al., 2003 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | [33] |
| 2 | Shen et al., 2005 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 7 | [37] |
| 3 | Shen et al., 2005 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 6 | [38] |
| 4 | Schöne et al., 2006 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 4 | [39] |
| 5 | Chaves et al., 2008 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 6 | [40] |
| 6 | Munakata et al., 2008 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 4 | [41] |
| 7 | Nakamura et al., 2008 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 7 | [42] |
| 8 | Suanarunsawat et al., 2009 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 8 | [43] |
| 9 | Asnaashari et al., 2010 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 | [44] |
| 10 | Khodambashi et al., 2012 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 7 | [45] |
| 11 | Batubara et al., 2013 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 7 | [46] |
| 12 | Caldas et al., 2013 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | [47] |
| 13 | Yamamoto et al., 2013 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 7 | [34] |
| 14 | Batubara et al., 2015 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 6 | [48] |
| 15 | Escobar et al., 2015 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 8 | [49] |
| 16 | Khosravinia, 2015 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 7 | [50] |
| 17 | Dahham et al., 2016 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 7 | [51] |
| 18 | Firmin et al., 2016 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 5 | [52] |
| 19 | Ogawa and Ito, 2016 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | [53] |
| 20 | Ogawa and Ito, 2016 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | [54] |
| 21 | Ogawa and Ito, 2016 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 8 | [55] |
| 22 | Ornaghi et al., 2017 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | [56] |
| 23 | Walia et al., 2017 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | [57] |
| 24 | Zhang et al., 2017 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 8 | [58] |
| 25 | Dehghani et al., 2018 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | [59] |
| 26 | Haque and Ansari, 2018 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 | [60] |
| 27 | Ogawa et al., 2018 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | [61] |
| 28 | Chapman et al., 2019 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 7 | [62] |
| 29 | Coelho-de-Souza et al., 2019 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | [63] |
| 30 | Mekonnen et al., 2019 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 8 | [64] |
| 31 | Ogawa and Ito, 2019 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | [65] |
| 32 | Hong et al., 2020 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 8 | [66] |
| 33 | Ogawa et al., 2020 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | [67] |
| 34 | Rossini et al., 2020 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 5 | [68] |
| 35 | Yokoyama et al., 2020 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 8 | [69] |
| 36 | Canche-Colli et al., 2021 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 7 | [70] |
| 37 | Lu et al., 2021 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 7 | [71] |
| 38 | Rafferty and Lamont, 2021 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | [72] |
| 39 | Torki et al., 2021 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 7 | [73] |
| 40 | Zhang et al., 2021 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 6 | [74] |
| 41 | Boaventura et al., 2022 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | [75] |
Criteria of quality assessment: (1) description of the sampling procedure or compound manufacturer; (2) mention of essential oil compositions; (3) detailed description of interventions; (4) use of positive controls; (5) specific mention of strains/species of animals used; (6) mention of test subject age; (7) mention of test subject weight; (8) mention or explanation of underlying mechanisms; (9) statement of potential conflict of interests; and (10) peer-reviewed publication.